Global X China Biotech ETF (HKG:2820)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
77.88
-2.10 (-2.63%)
Sep 26, 2025, 4:08 PM HKT
-2.63%
Assets650.92M
Expense Ratio0.68%
PE Ratio39.60
Dividend (ttm)n/a
Dividend Yieldn/a
Ex-Dividend Daten/a
Payout Frequencyn/a
Payout Ration/a
1-Year Return+77.57%
Volume67,352
Open77.70
Previous Close79.98
Day's Range77.54 - 78.54
52-Week Low42.10
52-Week High83.60
Beta0.79
Holdings30
Inception DateJul 25, 2019

About 2820

The Global X China Biotech ETF seeks to provide investment results that, before deduction of fees and expenses, closely correspond to the performance of the Underlying Index.

Asset Class Equity
Category Health Care
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2820
Provider Global X
Index Tracked Solactive China Biotech Index

Performance

2820 had a total return of 77.57% in the past year, including dividends. Since the fund's inception, the average annual return has been 7.44%.

Top 10 Holdings

69.46% of assets
NameSymbolWeight
WuXi Biologics (Cayman) Inc.226910.93%
WuXi AppTec Co., Ltd.60325910.09%
BeOne Medicines AGONC9.51%
Jiangsu Hengrui Medicine Co., Ltd.6002769.24%
Innovent Biologics, Inc.18018.60%
Akeso, Inc.99265.85%
Sino Biopharmaceutical Limited11775.67%
3SBio Inc.15303.96%
Hansoh Pharmaceutical Group Company Limited36923.00%
Shanghai RAAS Blood Products Co., Ltd.0022522.63%
View More Holdings